60 related articles for article (PubMed ID: 26133188)
1. Depletion of enteroantigen-activated CD4⁺ T cells: effects on proliferation and pathogenicity.
Belmaáti MS; Claesson MH
Int Immunol; 2015 Sep; 27(9):419-24. PubMed ID: 26133188
[TBL] [Abstract][Full Text] [Related]
2. Enteroantigen-presenting B cells efficiently stimulate CD4(+) T cells in vitro.
Schmidt EG; Kristensen NN; Claesson MH; Pedersen AE
Inflamm Bowel Dis; 2011 Jan; 17(1):308-18. PubMed ID: 20722062
[TBL] [Abstract][Full Text] [Related]
3. Characterization of T-regulatory cells, induced by immature dendritic cells, which inhibit enteroantigen-reactive colitis-inducing T-cell responses in vitro and in vivo.
Gad M; Kristensen NN; Kury E; Claesson MH
Immunology; 2004 Dec; 113(4):499-508. PubMed ID: 15554928
[TBL] [Abstract][Full Text] [Related]
4. Enteroantigen (eAg)-binding B lymphocytes in the mouse - phenotype, distribution, function and eAg-specific antibody secretion.
Venning FA; Trempenau ML; Schmidt E; Claesson MH
APMIS; 2014 Jul; 122(7):616-27. PubMed ID: 24303790
[TBL] [Abstract][Full Text] [Related]
5. Tolerogenic dendritic cells pulsed with enterobacterial extract suppress development of colitis in the severe combined immunodeficiency transfer model.
Pedersen AE; Gad M; Kristensen NN; Haase C; Nielsen CH; Claesson MH
Immunology; 2007 Aug; 121(4):526-32. PubMed ID: 17428312
[TBL] [Abstract][Full Text] [Related]
6. Enteric bacterial antigens activate CD4(+) T cells from scid mice with inflammatory bowel disease.
Brimnes J; Reimann J; Nissen M; Claesson M
Eur J Immunol; 2001 Jan; 31(1):23-31. PubMed ID: 11169434
[TBL] [Abstract][Full Text] [Related]
7. Demonstration of strong enterobacterial reactivity of CD4+CD25- T cells from conventional and germ-free mice which is counter-regulated by CD4+CD25+ T cells.
Gad M; Pedersen AE; Kristensen NN; Claesson MH
Eur J Immunol; 2004 Mar; 34(3):695-704. PubMed ID: 14991599
[TBL] [Abstract][Full Text] [Related]
8. Regulatory T cells restrain CD4+ T cells from causing unregulated immune activation and hypersensitivity to lipopolysaccharide challenge.
Okeke EB; Okwor I; Uzonna JE
J Immunol; 2014 Jul; 193(2):655-62. PubMed ID: 24943218
[TBL] [Abstract][Full Text] [Related]
9. B7-H4-Ig treatment of normal mice changes lymphocyte homeostasis and increases the potential of regulatory T cells.
Kristensen NN; Schmidt EG; Rasmussen S; Balk-Møller E; Claesson MH
Immunopharmacol Immunotoxicol; 2013 Aug; 35(4):505-13. PubMed ID: 23841452
[TBL] [Abstract][Full Text] [Related]
10. Induction of eye-derived tolerance does not depend on naturally occurring CD4+CD25+ T regulatory cells.
Keino H; Takeuchi M; Kezuka T; Hattori T; Usui M; Taguchi O; Streilein JW; Stein-Streilein J
Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):1047-55. PubMed ID: 16505040
[TBL] [Abstract][Full Text] [Related]
11. Transient role of CD4+CD25+ regulatory T cells in mycobacterial infection in mice.
Ozeki Y; Sugawara I; Udagawa T; Aoki T; Osada-Oka M; Tateishi Y; Hisaeda H; Nishiuchi Y; Harada N; Kobayashi K; Matsumoto S
Int Immunol; 2010 Mar; 22(3):179-89. PubMed ID: 20139174
[TBL] [Abstract][Full Text] [Related]
12. Cytotoxic reactivity of gut lamina propria CD4+ alpha beta T cells in SCID mice with colitis.
Bonhagen K; Thoma S; Bland P; Bregenholt S; Rudolphi A; Claesson MH; Reimann J
Eur J Immunol; 1996 Dec; 26(12):3074-83. PubMed ID: 8977307
[TBL] [Abstract][Full Text] [Related]
13. Regulatory dendritic cells pulsed with carbonic anhydrase I protect mice from colitis induced by CD4+CD25- T cells.
Yamanishi H; Murakami H; Ikeda Y; Abe M; Kumagi T; Hiasa Y; Matsuura B; Onji M
J Immunol; 2012 Mar; 188(5):2164-72. PubMed ID: 22291189
[TBL] [Abstract][Full Text] [Related]
14. Transforming growth factor beta induced FoxP3+ regulatory T cells suppress Th1 mediated experimental colitis.
Fantini MC; Becker C; Tubbe I; Nikolaev A; Lehr HA; Galle P; Neurath MF
Gut; 2006 May; 55(5):671-80. PubMed ID: 16162681
[TBL] [Abstract][Full Text] [Related]
15. Immunosenescent colitogenic CD4(+) T cells convert to regulatory cells and suppress colitis.
Totsuka T; Kanai T; Nemoto Y; Tomita T; Tsuchiya K; Sakamoto N; Okamoto R; Watanabe M
Eur J Immunol; 2008 May; 38(5):1275-86. PubMed ID: 18412161
[TBL] [Abstract][Full Text] [Related]
16. Colitis-inducing potency of CD4+ T cells in immunodeficient, adoptive hosts depends on their state of activation, IL-12 responsiveness, and CD45RB surface phenotype.
Claesson MH; Bregenholt S; Bonhagen K; Thoma S; Möller P; Grusby MJ; Leithäuser F; Nissen MH; Reimann J
J Immunol; 1999 Mar; 162(6):3702-10. PubMed ID: 10092833
[TBL] [Abstract][Full Text] [Related]
17. Polyclonal expansion of adoptively transferred CD4+ alpha beta T cells in the colonic lamina propria of scid mice with colitis.
Rudolphi A; Bonhagen K; Reimann J
Eur J Immunol; 1996 May; 26(5):1156-63. PubMed ID: 8647181
[TBL] [Abstract][Full Text] [Related]
18. Influence of intestinal bacteria on induction of regulatory T cells: lessons from a transfer model of colitis.
Strauch UG; Obermeier F; Grunwald N; Gürster S; Dunger N; Schultz M; Griese DP; Mähler M; Schölmerich J; Rath HC
Gut; 2005 Nov; 54(11):1546-52. PubMed ID: 15987795
[TBL] [Abstract][Full Text] [Related]
19. CXC chemokine receptor 3 expression increases the disease-inducing potential of CD4+ CD25- T cells in adoptive transfer colitis.
Kristensen NN; Gad M; Thomsen AR; Lu B; Gerard C; Claesson MH
Inflamm Bowel Dis; 2006 May; 12(5):374-81. PubMed ID: 16670526
[TBL] [Abstract][Full Text] [Related]
20. Antiproliferative effects of TRPV1 ligands on nonspecific and enteroantigen-specific T cells from wild-type and Trpv1 KO mice.
Belmaáti MS; Diemer S; Hvarness T; Baumann K; Pedersen AE; Christensen RE; Claesson MH
Inflamm Bowel Dis; 2014 Jun; 20(6):1004-14. PubMed ID: 24788222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
